FindTrial
Sign In

Expresssion and significiance of P38MAPK and JNK pathways in lymphocytes of Schizophrenia patients

Expresssion and significiance of mitogen activated protein kinase pathways in lymphocytes of Schizophrenia patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800020272
Enrollment
Unknown
Registered
2018-12-21
Start date
2019-03-01
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia

Interventions

Case series:Nil
Normal control:Nil

Sponsors

ShanDong Mental Health Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Aged 18 to 60 years, meet the standard of ICD - 10 in the diagnosis of schizophrenia.

Exclusion criteria

Exclusion criteria: 1) Serious adverse events; 2) other mental illness; 3) substance abuse or dependence; 4) an acute infection and autoimmune diseases; 5) nervous system disease or a history of trauma; 6) pregnant or lactating women; 7) schizophrenia with other serious mental disease.

Design outcomes

Primary

MeasureTime frame
P38MAPK, P-P38MAPK, JNK?P-JNK;—

Countries

China

Contacts

Public ContactLiu Zengxun

Shandong Mental Health Center

zengxunliu@126.com+86 13583135343

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026